- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- Analysis
- Focus Articles1 new
- Related Articles3 new
- Instablogs
- StockTalks
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
MYL Market Currents
more »
-
May 11 Mylan (MYL) says it will launch sales of its generic version of Lipitor in France, Belgium, the U.K., the Netherlands and Ireland after winning regulatory approvals in each country. Atorvastatin Calcium serves as a generic version of Pfizer's Lipitor drug for the prevention of heart attacks.
Comment![Healthcare]
MYL Related Articles
more »
MYL News
more »
-
at MarketWatch.com (May 4, 2012)
-
at MarketWatch.com (Apr 30, 2012)
-
at MarketWatch.com (Apr 26, 2012)
-
at MarketWatch.com (Apr 21, 2012)
-
at CNBC.com (Apr 19, 2012)
MYL Press Releases and Filings
more »
-
PR Newswire (Thu, 1:41PM)
-
PR Newswire (May 14, 2012)
-
PR Newswire (May 11, 2012)
-
PR Newswire (May 10, 2012)
-
PR Newswire (Apr 30, 2012)
MYL Latest Transcript
more »
MYL Cramer
more »
-
Tue, Jan 12, 2010
-
Fri, Jul 24, 2009
-
Mon, Jun 4, 2007
MYL Instablog posts
more »
MYL vs. ETF Alternatives
Company Description
Long considered a leader in the United States (“U.S.”) generic pharmaceutical market, Mylan has grown into a worldwide pharmaceutical leader and is currently the third largest generic and specialty pharmaceutical company in the world, in terms of revenues. This evolution has taken place through... More
